Page 310 - Rep News Today

China's yuan touched a one-week high against the dollar on Monday, on corporate demand for the local currency and easing worries over the spread of the Omicron coronavirus variant.

Philippine shares tumbled on Monday, while the Thai baht eased as financial markets were on edge on concerns the new Omicron variant of the coronavirus could derail a nascent re-opening of economies around the world.

Securities analysts revised their ratings and price targets on several European companies, including A.P. Moller-Maersk, Homeserve and Swiss Prime Site AG, on Monday.

Gold prices edged higher on Monday as concerns over the impact of the Omicron coronavirus variant offset a stronger dollar, with investors assessing whether the emergence of the variant could change the U.S. Federal Reserve's hawkish stance.

Bargain buying in technology stocks drove Wall Street higher on Monday following a slump related to Omicron, while the Dow Jones lagged its peers as major banks fell and investors awaited more information on the new coronavirus variant.

Central European currencies and stocks recovered on Monday, as a global risk-off mood triggered by the newly identified coronavirus variant found in South Africa has faded away.

South Korean exports likely grew for a 13th straight month in November, a Reuters poll showed on Monday, while the pace of inflation growth is expected to be near a decade high as global energy prices remain high.

Asian oil refiners' margins have slumped to the lowest in nearly five months amid worries that the Omicron coronavirus variant could deal another blow to oil demand recovery, already hit by rising COVID-19 cases in Europe.

Gold prices edged higher on Monday, as concerns over the impact of the possibly vaccine-resistant Omicron coronavirus variant supported the precious metal's safe-haven appeal.

The Australian dollar recovered against the greenback on Monday after sliding last week as spooked investors scaled back bets of global monetary tightening on worries the Omicron coronavirus variant may be harder to combat with vaccines.